Vicarious Surgical Q2 net loss $15.2M; cash burn $10.9M, reiterates FY2024 ~$50M

Vicarious Surgical Inc.

2024-Q2 EPS reported -$5.49

GAAP net loss $15.2M ($2.59/sh) vs $15.3M ($3.62/sh) in Q2 2023; adjusted net loss $16.8M ($2.86/sh).
Operating expenses $17.7M, down 17% YoY; R&D $10.9M, G&A $5.6M, S&M $1.2M.
Cash and investments $73.2M as of June 30, 2024; Q2 2024 cash burn $10.9M.
Reaffirmed full-year 2024 cash burn guidance of approximately $50 million.
Partnered with LSU Health New Orleans as fifth U.S. hospital system; V1.0 integration milestone on track for fall 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.